Chu et al., identified perillaldehyde (PAH), a natural monoterpenoid derived from Perilla frutescens, as an effective inhibitor of cGAS signaling in the preclinical AGS model [197]. This evidence concerns the gene CGAS and Aicardi-Goutieres syndrome.